Related Experiment Video
Updated: Jun 24, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Association of Interleukin-6 (rs1800795) and Interleukin-10 (rs1800896) Genetic Polymorphisms with the Outcome of
Mahmoud El-Bendary1,2, Mustafa Naemattalah2,3, Hatem Elalfy1,2
1Tropical Medicine and Hepatogastroenterology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Insights
Genetic variations in interleukin-6 (IL-6) and interleukin-10 (IL-10) genes are linked to COVID-19 severity. The C allele of IL-6 (rs1800795) and IL-10 (rs1800896) were significantly associated with severe COVID-19 outcomes.
Area of Science:
- Immunogenetics
- Infectious Disease Epidemiology
- Molecular Biology
Background:
- The COVID-19 pandemic highlights the need to understand factors influencing disease severity.
- Genetic polymorphisms, particularly in cytokine genes, may play a role in differential host responses to SARS-CoV-2 infection.
Purpose of the Study:
- To investigate the association between specific genetic polymorphisms in interleukin-6 (IL-6) and interleukin-10 (IL-10) genes and the clinical outcomes of COVID-19.
- To determine if these genetic variations correlate with disease severity (moderate vs. severe) and mortality.
Main Methods:
- A cross-sectional study involving 354 COVID-19 patients categorized into moderate and severe groups.
- Genotyping was performed for single nucleotide polymorphisms (SNPs) IL-6 rs1800795 and IL-10 rs1800896 using real-time PCR.
- Statistical analysis was employed to compare allele frequencies between patient groups.
Main Results:
- The C allele of IL-6 rs1800795 was significantly more prevalent in severe COVID-19 cases compared to moderate cases (p < 0.0001).
- The C allele of IL-10 rs1800896 also showed a significant increase in severe cases versus moderate cases (p < 0.0001).
- IL-6 C allele carriage showed a mild significant association with mortality (alive vs. deceased, p < 0.04), while IL-10 did not show a significant difference in mortality.
Conclusions:
- The C alleles of IL-6 rs1800795 and IL-10 rs1800896 are significantly associated with increased severity of COVID-19.
- IL-6 genetic variations may influence survival outcomes in COVID-19 patients, warranting further investigation.
Abstract:
The corona virus disease-2019 (COVID-19) pandemic has affected most of the world with varying degrees of morbidity and mortality. The presence of genetic polymorphisms may be associated with the severity and outcome of COVID-19 infection. This work aimed to evaluate the genetic polymorphisms of interleukin (IL-6) and IL-10 genes with the outcome of COVID-19 infection. This cross-sectional study was conducted on 354 patients who were classified into moderate and severe cases (including alive and deceased cases). All individuals were genotyped for one SNP for IL-6 (rs1800795) and one SNP for IL10 (rs1800896) using allelic discrimination real-time PCR technique. In this study, 198 cases were moderate, and 156 cases were severe. The risk of allele carriage of the minor allele of IL-6 rs1800795 (C) was significantly higher among the severe group when compared with that of the moderate group (p < 0.0001), while there was a mild significant difference of same allele carriage among alive cases when compared to that of deceased one (p < 0.04). Furthermore, the risk of the C allele of IL-10 rs1800896 was significantly increased in severe cases when compared with the moderate group (p < 0.0001), while there was no significant difference of the risk of the C allele in deceased cases when compared with that of alive ones (p > 0.05). In conclusion, the C allele (rs1800795) of IL-6 and the C allele (rs1800896) of IL-10 were highly significant in severe cases than in moderate cases. The C allele carriage of IL-6 showed only a significant difference between alive and deceased patients and not with the C allele of IL-10.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
The JAK-STAT Signaling Pathway
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pleiotropy